Two	O
of	O
the	O
main	O
reasons	O
people	O
switch	O
to	O
cannabis	O
from	O
pharmaceuticals	O
and	O
other	O
drugs	O
such	O
as	O
alcohol	O
:	O
less	O
side-effects	O
and	O
less	O
withdrawal	O
:	O
"	O
Over	O
41%	O
state	O
that	O
they	O
use	O
cannabis	O
as	O
a	O
substitute	O
for	O
alcohol	O
,	O
36.1%	O
use	O
cannabis	O
as	O
a	O
substitute	O
for	O
illicit	O
substances	O
,	O
and	O
67.8%	O
use	O
cannabis	O
as	O
a	O
substitute	O
for	O
prescription	O
drugs	O
.	O
The	Premise-B
three	Premise-I
main	Premise-I
reasons	Premise-I
cited	Premise-I
for	Premise-I
cannabis-related	Premise-I
substitution	Premise-I
are	Premise-I
'	Premise-I
less	Premise-I
withdrawal	Premise-I
'	Premise-I
(	Premise-I
67.7%	Premise-I
)	Premise-I
,	Premise-I
'	Premise-I
fewer	Premise-I
side-effects	Premise-I
'	Premise-I
(	Premise-I
60.4%	Premise-I
)	Premise-I
,	Premise-I
and	Premise-I
'	Premise-I
better	Premise-I
symptom	Premise-I
management	Premise-I
'	Premise-I
suggesting	Premise-I
that	Premise-I
many	Premise-I
patients	Premise-I
may	Premise-I
have	Premise-I
already	Premise-I
identified	Premise-I
cannabis	Premise-I
as	Premise-I
an	Premise-I
effective	Premise-I
and	Premise-I
potentially	Premise-I
safer	Premise-I
adjunct	Premise-I
or	Premise-I
alternative	Premise-I
to	Premise-I
their	Premise-I
prescription	Premise-I
drug	Premise-I
regimen	Premise-I
.	Premise-I
"	Premise-I
[	O
Lucas	O
et	O
al	O
.	O
Cannabis	O
as	O
a	O
substitute	O
for	O
alcohol	O
and	O
other	O
drugs	O
:	O
A	O
dispensary-based	O
survey	O
of	O
substitution	O
effect	O
in	O
Canadian	O
medical	O
cannabis	O
patients	O
.	O
Addiction	O
Research	O
&	O
Theory	O
.	O
2013	O
]	O
